DNASE1L3 and melanoma: The antimetastatic and antitumor effect of bpDNase I and its ability to destroy tumor-derived cfDNA has been demonstrated in murine models of melanoma B16 and resistant lymphosarcoma RLS40, which indicates the general patterns of the DNase I functioning in metastases and tumor inhibition [63].